As of or For the
Three Months Ended
March 31, 2025

Previously

Report

Restatement
Adjustments

Restated

Condensed Balance Sheet

Additional Paid In Capital

78,984,884

5,675,971

73,308,913

Accumulated Deficit^(b)

(88,610,432

)

(5,675,971

)

(82,934,461

)

Condensed Statement of Operations

Share based Compensation^(b)(c)

23,073,745

5,675,971

17,397,774

Total Operating Expense

37,616,803

5,675,971

31,940,832

Loss from operations

(37,576,813

)

(5,675,971

)

(31,900,842

)

Net loss^(a)(b)

(38,001,987

)

(5,675,971

)

(32,326,016

)

Net loss per share

(2.10

)

(0.32

)

(1.78

)

Condensed Statement of Cashflows

Net Loss

(38,001,987

)

(5,675,971

)

(32,326,016

)

Share based compensation adjustment

23,073,745

5,675,971

17,397,774

Notes to the Condensed Consolidated Financial Statement

Note 8 - Stock-Based Compensation

Fair value of RSUs at respective grant date

37,336,500

(5,839,992

)

31,496,508

Unamortized portion

14,262,755

(164,021

)

14,098,734

Remaining term

1.8

(1.0

)

0.8

Catch up amortization as of the listing date

22,756,463

(5,608,537

)

17,147,463